Unicycive Therapeutics Q4 EPS $(0.35) Misses $(0.17) Estimate
UNICYCIVE THERAPEUTICS, INC. -2.63%
UNICYCIVE THERAPEUTICS, INC.
UNCY
|
0.64
|
-2.63%
|
Unicycive Therapeutics (NASDAQ:
UNCY) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.17) by 105.88 percent. This is a 31.37 percent increase over losses of $(0.51) per share from the same period last year.